P&S Intelligence

The global industrial software market is set to hit USD 134B by 2032, driven by digital transformation, smart factories, and Industry 4.0 adoption.

Global contrast media market to reach USD 8.3B by 2032, driven by rising chronic diseases, AI integration, and growing demand for advanced diagnostic imaging.

The healthcare bioconvergence market will reach USD 248.7B by 2032, driven by AI, nanotech, and regenerative medicine innovations.

The healthcare fraud analytics market will surge from USD 2.3B in 2024 to USD 20.3B by 2032, driven by AI, rising fraud cases, and stricter regulations.

Global fermenter market to reach USD 2.6B by 2032, driven by biopharma, food & beverage, and sustainable protein demand, growing at 6.5% CAGR.

Global cell & gene therapy manufacturing market to reach $27B by 2032, driven by clinical trials, outsourcing, and advances in personalized medicine.

The global depyrogenated sterile empty vials market is set to reach USD 5,075M by 2032, driven by biologics, vaccines, and advanced depyrogenation technologies.

Single-use bioreactors are transforming biomanufacturing, driving efficiency, flexibility, and cost savings, with the market set to reach $19.9B by 2032.

Global amniotic products market to reach $1.66B by 2032, driven by aging population, regenerative medicine, and advanced wound & ophthalmic care.

The global satellite spectrum monitoring market is set to reach USD 5.94 billion by 2030, driven by satellite proliferation, signal interference, and tech advancements.